Literature DB >> 32057776

Kozen Yoshino's experimental infections with Taenia solium tapeworms: An experiment never to be repeated.

Akira Ito1, Mika Saito2, Meritxell Donadeu3, Marshall W Lightowlers4.   

Abstract

In the 1930's Kozen Yoshino published 6 papers on Taenia solium. One of these papers is particularly important because it describes the outcomes of experimental infections with T. solium tapeworms in four volunteers, Yoshino being one of them. The paper was written in an old form of the Japanese language, making it almost inaccessible to most researchers around the world. Here we provide a non-literal translation of this work and some brief comments by the translators. Each of the four volunteers swallowed three or five cysticerci recovered from an experimentally infected pig. Each person was found to have harbored 2 - 5 tapeworms when the infections were terminated by drug treatment between 120 and 451 days after infection. The pre-patent period recorded by Yoshino's volunteers was between 62 and 72 days based on the first appearance of gravid proglottids (GPs) in the feces. In one subject, the number of GPs appearing in each bowel movement was tracked daily for 371 days following the first appearance of GPs in the feces, together with the number of bowel movements each day. GPs were observed on 275 of the 284 days on which the subject defecated during which observations were made. There was a decline in the number of GPs over the observation period; proglottids were observed on 97% of all days on which defecation occurred, they were present on 87% of days in the last month of infection. The cumulative number of GPs for a month in the 1st, 6th and 12th months of patent infection was 334, 174 and 126, respectively.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Experimental infection; Kozen Yoshino; Prepatent period; Proglottid's outcome; Taenia solium; Taeniasis

Year:  2020        PMID: 32057776     DOI: 10.1016/j.actatropica.2020.105378

Source DB:  PubMed          Journal:  Acta Trop        ISSN: 0001-706X            Impact factor:   3.112


  6 in total

1.  Impact of a 3-year mass drug administration pilot project for taeniasis control in Madagascar.

Authors:  Noromanana Sylvia Ramiandrasoa; Pascaline Ravoniarimbinina; Armand Rafalimanantsoa Solofoniaina; Iharilanto Patricia Andrianjafy Rakotomanga; Samuel Hermas Andrianarisoa; Sophie Molia; Anne-Marie Labouche; Anna Sophie Fahrion; Meritxell Donadeu; Bernadette Abela-Ridder; Davidra Rajaonatahina
Journal:  PLoS Negl Trop Dis       Date:  2020-09-18

2.  Case Report: Disseminated Cysticercosis due to Intentional Ingestion of Parasitic Worm Eggs for Weight Loss.

Authors:  Han-Yu Zhang; Guo-Xing Wang; Yue-Yan Xing; Miao-Rong Xie
Journal:  Am J Trop Med Hyg       Date:  2021-11-29       Impact factor: 2.345

Review 3.  Perspectives on intestinal tapeworm infections: An evaluation of direct and indirect life-cycles with a special emphasis on species of Hymenolepis.

Authors:  Akira Ito; Christine M Budke
Journal:  Curr Res Parasitol Vector Borne Dis       Date:  2021-04-14

Review 4.  Genetic Diversity of Taenia solium and its Relation to Clinical Presentation of Cysticercosis.

Authors:  Akira Ito; Christine M Budke
Journal:  Yale J Biol Med       Date:  2021-06-30

5.  New insights on the Taenia solium tapeworm using molecular tools: age-based human definitive host prevalence and deliberation on parasite life span.

Authors:  Tiaoying Li; Xingwang Chen; Christine M Budke; Yuangui Zhou; Mianchuan Duan; Celine Wang; Bo Zhong; Yang Liu; Jianying Luo; Wei He; Jingye Shang; Akira Ito
Journal:  Pathog Glob Health       Date:  2021-05-24       Impact factor: 2.894

6.  Risk factors and prevalence of taeniasis among the Karen people of Tha Song Yang District, Tak Province, Thailand.

Authors:  Teera Kusolsuk; Kittipong Chaisiri; Akkarin Poodeepiyasawad; Surapol Sa-Nguankiat; Nirundorn Homsuwan; Tetsuya Yanagida; Munehiro Okamoto; Dorn Watthanakulpanich; Jitra Waikagul; Paron Dekumyoy; Chalit Komalamisra; Akira Ito
Journal:  Parasite       Date:  2021-06-18       Impact factor: 3.000

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.